FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

18559311000001106: Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63729401000001114 Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
75309701000001115 Quinine sulfate 300mg tablets (Bristol Laboratories Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely quinine sulfate 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has active ingredient Quinine sulfate false Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Quinine sulfate true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) 28 tablet Has AMP True Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) 500 tablet Has AMP True Quinine sulphate 300mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start